THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL TRANSPLANTATION^{1, 2}

³Address reprint requests to: Dr. Barry D. Kahan, Division of Immunology and Organ Transplantation, Department of Surgery, The University of Texas Medical School at Houston, 6431 Fannin, Suite 6240 MSB, Houston Tx 77030.

Division of Immunology and Organ Transplantation, Department of Surgery, The University of Texas Medical School of Houston, Houston, Texas 77030